Wuxi Apptec Co Unsp/Adr (WUXAY) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hi, good morning, everyone. For those who are based in China and Hong Kong, and good evening for those based in the U.S. This is the 2025 Wuxi Aptec results call. My name is Lawrence Tam. I'm a China healthcare analyst at Morgan Stanley. We're honored today to have the full team from Wuxi Aptec to present the 2025 results in English. The format of the call will be two parts. First, I'll let management go through their prepared remarks. You can refer to the slides on the webcast. And then the second part will be a Q&A session. To ask questions, simply open the link that was sent to you during the registration. And you can type your questions into the Q&A box at the bottom of the window. You can also send me your questions at the following email, lawrence, L-A-U-R-E-N-C-E, .T-A-M, at morgansandlee.com. And I'll repeat your questions to management. With that, let me now pass it on to the head of IR at Wuxi App Tech, Ms. Tang Rui-Chiang, to introduce management and to start the prepared remarks. I'll pass it on to you, Rui-Chiang. Okay. Thank you, Lawrence. Welcome, everyone, to Wuxi App Tech's 2025 Annual Results Conference Call. We released our financial results last night and have posted the latest on our company website. During today's call, we will make forward-looking statements. Although we believe that our predictions are reasonable, future events are uncertain, and our forward-looking statements may turn out to be incorrect. Accordingly, you are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. In addition, to supplement the company's consolidated financial statements presented in accordance with IFRS, We provide adjusted IFRS financial data. We believe the adjusted financial measures are usefu...